If a variant has more than one submission, it may be counted in more than one significance column. If this is the
case, the total number of variants will be less than the sum of the other cells.
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
33
|
11
|
346
|
409
|
40
|
1
|
829
|
Gene and significance breakdown #
Total genes and gene combinations: 9
Gene or gene combination |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
CNTN2
|
22
|
11
|
302
|
378
|
30
|
0 |
733
|
CNTN2, LOC126805985
|
3
|
0 |
25
|
29
|
4
|
0 |
61
|
YEATS2
|
1
|
0 |
5
|
2
|
6
|
0 |
14
|
ADRA2B
|
0 |
0 |
5
|
0 |
0 |
1
|
5
|
SAMD12
|
3
|
0 |
2
|
0 |
0 |
0 |
5
|
STARD7
|
2
|
0 |
3
|
0 |
0 |
0 |
5
|
MARCHF6
|
2
|
0 |
2
|
0 |
0 |
0 |
4
|
ADIPOR1, ADORA1, ARL8A, ASCL5, ATP2B4, AVPR1B, BTG2, CACNA1S, CAMSAP2, CDK18, CHI3L1, CHIT1, CNTN2, CSRP1, CTSE, CYB5R1, DDX59, DSTYK, DYRK3, EIF2D, ELF3, ELK4, ETNK2, FAM72A, FMOD, GOLT1A, GPR25, GPR37L1, IGFN1, IKBKE, IL10, INAVA, IPO9, KDM5B, KIF14, KIF21B, KISS1, KLHDC8A, KLHL12, LAD1, LAX1, LEMD1, LGR6, LMOD1, LRRN2, MAPKAPK2, MDM4, MFSD4A, MYBPH, MYOG, NAV1, NFASC, NUAK2, NUCKS1, OPTC, PCAT6, PHLDA3, PIK3C2B, PKP1, PLEKHA6, PM20D1, PPFIA4, PPP1R12B, PPP1R15B, PRELP, PTPN7, RAB29, RABIF, RASSF5, RBBP5, REN, RHEX, RNPEP, SHISA4, SLC26A9, SLC41A1, SLC45A3, SNRPE, SOX13, SRGAP2, SYT2, TIMM17A, TMCC2, TMEM183A, TMEM81, TMEM9, TNNI1, TNNT2, UBE2T, ZBED6, ZC3H11A
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
LOC129934328, STARD7
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Submitter and significance breakdown #
Submitter |
pathogenic |
likely pathogenic |
uncertain significance |
likely benign |
benign |
not provided |
total |
Labcorp Genetics (formerly Invitae), Labcorp
|
22
|
10
|
315
|
405
|
33
|
0 |
785
|
New York Genome Center
|
0 |
0 |
12
|
0 |
0 |
0 |
12
|
Fulgent Genetics, Fulgent Genetics
|
0 |
0 |
6
|
4
|
1
|
0 |
11
|
Genome-Nilou Lab
|
0 |
0 |
0 |
0 |
9
|
0 |
9
|
OMIM
|
7
|
0 |
1
|
0 |
0 |
0 |
8
|
Baylor Genetics
|
0 |
0 |
6
|
0 |
0 |
0 |
6
|
Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago
|
0 |
0 |
4
|
0 |
0 |
0 |
4
|
Revvity Omics, Revvity
|
0 |
0 |
3
|
0 |
0 |
0 |
3
|
Genomic Medicine Center of Excellence, King Faisal Specialist Hospital and Research Centre
|
0 |
0 |
2
|
1
|
0 |
0 |
3
|
Centogene AG - the Rare Disease Company
|
0 |
1
|
1
|
0 |
0 |
0 |
2
|
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Mendelics
|
0 |
0 |
0 |
0 |
1
|
0 |
1
|
Mayo Clinic Laboratories, Mayo Clinic
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Genomic Research Center, Shahid Beheshti University of Medical Sciences
|
0 |
0 |
1
|
0 |
0 |
0 |
1
|
Neurogenetics Research Program, University of Adelaide
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
GenomeConnect, ClinGen
|
0 |
0 |
0 |
0 |
0 |
1
|
1
|
Institute for Human Genetics, University Hospital Essen
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
The Walter and Eliza Hall Institute of Medical Research
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Excellence Center for Genomics and Precision Medicine, King Chulalongkorn Memorial Hospital
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
3billion, Medical Genetics
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
Rare Genetic Disease Lab, Dept of Zoology, Government Postgraduate College Dargai Malakand, Higher Education Govt. of Khyber Pakhtunkhwa
|
1
|
0 |
0 |
0 |
0 |
0 |
1
|
The information on this website is not intended for direct
diagnostic use or medical decision-making without review by a
genetics professional. Individuals should not change their
health behavior solely on the basis of information contained on
this website. Neither the University of Utah nor the National
Institutes of Health independently verfies the submitted
information. If you have questions about the information
contained on this website, please see a health care
professional.